Longitudinal Epigenome-Wide Analysis of Kidney Transplant Recipients Pretransplant and Posttransplant.
Longitudinal Epigenome-Wide Analysis of Kidney Transplant Recipients Pretransplant and Posttransplant.
复制标题
DOI:
10.1016/j.ekir.2022.11.001
复制
发表时间:
2023-02
影响因子:
6
通讯作者:
McKnight, Amy Jayne
中科院分区:
文献类型:
--
作者:
Smyth, Laura J.;Kerr, Katie R.;Kilner, Jill;McGill, Aine E.;Maxwell, Alexander P.;McKnight, Amy Jayne
关键词:
Kidney transplantation remains the gold standard of treatment for end-stage renal disease (ESRD), with improved patient outcomes compared with dialysis. Epigenome-Wide Association Analysis (EWAS) of DNA methylation may identify markers that contribute to an individual’s risk of adverse transplant outcomes, yet only a limited number of EWAS have been conducted in kidney transplant recipients. This EWAS aimed to interrogate the methylation profile of a kidney transplant recipient cohort with minimal posttransplant complications, exploring differences in samples pretransplant and posttransplant. We compared differentially methylated cytosine-phosphate-guanine sites (dmCpGs) in samples derived from peripheral blood mononuclear cells of the same kidney transplant recipients, collected both pretransplant and posttransplant (N = 154), using the Infinium MethylationEPIC microarray (Illumina, San Diego, CA). Recipients received kidneys from deceased donors and had a mean of 17 years of follow-up. Five top-ranked dmCpGs were significantly different at false discovery rate (FDR) adjusted P ≤ 9 × 10−8; cg23597162 within JAZF1, cg25187293 within BTNL8, cg17944885, located between ZNF788P and ZNF625-ZNF20, cg14655917 located between ASB4 and PDK4 and cg09839120 located between GIMAP6 and EIF2AP3. Five dmCpGs were identified at the generally accepted EWAS critical significance level of FDR adjusted P (PFDRadj) ≤ 9 × 10−8, including cg23597162 (within JAZF1) and cg17944885, which have prior associations with chronic kidney disease (CKD). Comparing individuals with no evidence of posttransplant complications (N = 105) demonstrated that 693,555 CpGs (89.57%) did not display any significant difference in methylation (PFDRadj ≥ 0.05), thereby this study establishes an important reference for future epigenetic studies that seek to identify markers of posttransplant complications.
登录
查看更多内容
影响因子:
14.9
作者:
Gene Ontology Consortium
通讯作者:
Gene Ontology Consortium
影响因子:
16.6
作者:
Chu AY;Tin A;Schlosser P;Ko YA;Qiu C;Yao C;Joehanes R;Grams ME;Liang L;Gluck CA;Liu C;Coresh J;Hwang SJ;Levy D;Boerwinkle E;Pankow JS;Yang Q;Fornage M;Fox CS;Susztak K;Köttgen A
通讯作者:
Köttgen A
影响因子:
12.3
作者:
Breeze CE;Batorsky A;Lee MK;Szeto MD;Xu X;McCartney DL;Jiang R;Patki A;Kramer HJ;Eales JM;Raffield L;Lange L;Lange E;Durda P;Liu Y;Tracy RP;Van Den Berg D;NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, TOPMed MESA Multi-Omics Working Group;Evans KL;Kraus WE;Shah S;Tiwari HK;Hou L;Whitsel EA;Jiang X;Charchar FJ;Baccarelli AA;Rich SS;Morris AP;Irvin MR;Arnett DK;Hauser ER;Rotter JI;Correa A;Hayward C;Horvath S;Marioni RE;Tomaszewski M;Beck S;Berndt SI;London SJ;Mychaleckyj JC;Franceschini N
通讯作者:
Franceschini N
影响因子:
64.5
作者:
Barros, Rafael Di Marco;Roberts, Natalie A.;Dart, Robin J.;Vantourout, Pierre;Jandke, Anett;Nussbaumer, Oliver;Deban, Livija;Cipolat, Sara;Hart, Rosie;Iannitto, Maria Luisa;Laing, Adam;Spencer-Dene, Bradley;East, Philip;Gibbons, Deena;Irving, Peter M.;Pereira, Pablo;Steinhoff, Ulrich;Hayday, Adrian
通讯作者:
Hayday, Adrian
影响因子:
4.5
作者:
Dayeh T;Volkov P;Salö S;Hall E;Nilsson E;Olsson AH;Kirkpatrick CL;Wollheim CB;Eliasson L;Rönn T;Bacos K;Ling C
通讯作者:
Ling C